Importer of Controlled Substances Application: Cambrex Charles City, 14892 [2016-06102]
Download as PDF
<![CDATA[
14892
Federal Register / Vol. 81, No. 53 / Friday, March 18, 2016 / Notices
collateral attack on the State Board’s
proceeding, whose order suspending her
state authority remains in effect as of
this date. The Agency has held,
however, ‘‘that a registrant cannot
collaterally attack the result of a state
criminal or administrative proceeding in
a proceeding under section 304, 21
U.S.C. 824, of the CSA.’’ Muzaffer
Aslan, 77 FR 37068, 37069 (2012) (other
citations omitted). ‘‘Rather,
Respondent’s challenge to the validity
of the [Nursing Board’s] Order must be
litigated in the forums provided by the
State of [Arkansas], and [her]
contentions regarding the validity of the
[Board’s] order are not material to this
Agency’s resolution of whether [she] is
entitled to maintain [her] DEA
registration in’’ Arkansas. Id.
Because it is undisputed that
Respondent’s Arkansas Advanced
Practice Nursing License remains
suspended, I find that she no longer has
authority under the laws of Arkansas,
the State in which she is registered, to
dispense controlled substances. See
Ark. Code Ann. Section 17–87–310
(b)(1) (‘‘An advanced practice registered
nurse with a certificate of prescriptive
authority may receive and prescribe
drugs, medicines, or therapeutic devices
appropriate to the advanced practice
registered nurse’s areas of practice in
accordance with rules established by the
Arkansas State Board of Nursing.’’).
Therefore, she is not entitled to
maintain her DEA registration. See 21
U.S.C. 802(21), 823(f), 824(a)(3).
Accordingly, I will order that her
registration be revoked and that any
pending application to renew or modify
her registration be denied.3
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b), I order that DEA
Certificate of Registration MR1972632,
3 While Respondent also asked that I stay the
revocation of her registration pending the resolution
of the criminal case and nursing board proceeding,
I decline to do so. As the Agency has previously
explained, ‘‘in circumstances similar to those raised
by Respondent, DEA has repeatedly denied requests
to stay the issuance of a final order of revocation,
noting that [u]nder the Controlled Substances Act,
a practitioner must be currently authorized to
handle controlled substances in the jurisdiction in
which [she] practices in order to maintain [her]
DEA registration.’’ Gregory F. Saric, 76 FR 16821,
16822 (2011) (internal quotations and citations
omitted). Of further note, Respondent’s advanced
practice nursing license was suspended more than
8 months ago, and yet her license still remains
suspended. And while Respondent asserts that the
Nursing Board’s suspension is the result of the
wrongful indictment, she ignores that the Board’s
order also relied on her having ‘‘prescribed opioids
from November 13, 2014 through January 7, 2015
without prescriptive authority.’’ Nursing Board
Order, at 2.
VerDate Sep<11>2014
19:50 Mar 17, 2016
Jkt 238001
issued to Kristen Lee Raines, A.P.R.N.,
be, and it hereby is, revoked. I further
order that any application of Kristen Lee
Raines, A.P.R.N., to renew or modify
this registration be, and it hereby is,
denied. This Order is effective
immediately.4
Dated: March 11, 2016.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2016–06103 Filed 3–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambrex Charles City
ACTION:
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 31,
2015, Cambrex Charles City, 1205 11th
Street, Charles City, Iowa 50616–3466
applied to be registered as an importer
of coca leaves (9040), a basic class of
controlled substance.
The company plans to import the
listed controlled substance for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Dated: March 8, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–06102 Filed 3–17–16; 8:45 am]
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
April 18, 2016. Such persons may also
file a written request for a hearing on
the application pursuant to 21 CFR
1301.43 on or before April 18, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments
and request for hearings on application
to import narcotic raw material are not
appropriate. 72 FR 3417 (January 25,
2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
DATES:
4 For the same reasons which led the Nursing
Board to conclude ‘‘that an emergency exists
constituting a threat to the public health, safety and
welfare’’ and to order the summary suspension of
Respondent’s licenses, I conclude that the public
interest necessitates that this Order be effective
immediately. 21 CFR 1316.67.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Employment and Training
Administration
Agency Information Collection
Activities; Comment Request for State
Retention of Applications and Job
Orders
ACTION:
Notice.
The Department of Labor
(DOL) is soliciting comments
concerning a proposed extension
without changes of the data retention
required by CFR 652.8(d)(5) of the
Wagner-Peyser Act. This comment
request is part of continuing
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq.
DATES: Consideration will be given to all
written comments received by May 17,
2016.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free by contacting the
U.S. Department of Labor, Employment
and Training Administration, Attention:
Adriana Kaplan, by telephone at (202)
693–3740 (this is not a toll free number),
by email, at kaplan.adriana@dol.gov,
TTY/TDD, 1–877–889–5627, (this is a
toll-free number), by fax at (202) 693–
3587, or by email at 200 Constitution
Avenue NW., Room S–4209,
Washington, DC 20210.
SUMMARY:
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 81, Number 53 (Friday, March 18, 2016)]
[Notices]
[Page 14892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06102]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Cambrex Charles
City
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before April 18, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before April 18, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
Comments and request for hearings on application to import narcotic raw
material are not appropriate. 72 FR 3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on July
31, 2015, Cambrex Charles City, 1205 11th Street, Charles City, Iowa
50616-3466 applied to be registered as an importer of coca leaves
(9040), a basic class of controlled substance.
The company plans to import the listed controlled substance for
internal use, and to manufacture bulk intermediates for sale to its
customers.
Dated: March 8, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-06102 Filed 3-17-16; 8:45 am]
BILLING CODE 4410-09-P
